Valuation: Haemonetics Corporation

Market Cap 413.11Cr 356.81Cr 335.29Cr 304.93Cr 573.29Cr 40TCr 582.74Cr 3.93TCr 1.54TCr 20TCr 1.55TCr 1.52TCr 66TCr P/E 2027 *
22.9x
P/E 2028 * 20.1x
Enterprise Value 479.32Cr 413.98Cr 389.02Cr 353.79Cr 665.16Cr 46TCr 676.12Cr 4.56TCr 1.78TCr 23TCr 1.8TCr 1.76TCr 76TCr EV / Sales 2027 *
3.39x
EV / Sales 2028 * 2.99x
Free-Float
98.74%
Yield 2027 *
2.2%
Yield 2028 * -
1 day+0.46%
1 week+3.37%
Current month+6.15%
1 month+18.41%
3 months+61.31%
6 months+57.20%
Current year+13.29%
1 week 85.97
Extreme 85.9701
92.25
1 month 74.95
Extreme 74.95
92.25
Current year 51
Extreme 51
92.25
1 year 47.32
Extreme 47.315
92.25
3 years 47.32
Extreme 47.315
97.97
5 years 43.5
Extreme 43.5
97.97
10 years 32.76
Extreme 32.76
142.11
Manager TitleAgeSince
Chief Executive Officer 62 16/05/2016
Director of Finance/CFO 55 11/04/2022
Chief Operating Officer 56 01/04/2025
Director TitleAgeSince
Director/Board Member 73 01/01/2006
Director/Board Member 62 16/05/2016
Director/Board Member 71 18/10/2017
Date Insider Type Main position Quantity % Market Cap.
24/07/26 Free

Director

2,538 0.0056%
24/07/26 Free

Director

2,538 0.0056%
24/07/26 Free

Director

2,538 0.0056%
Change 5-day change 1-year change 3-year change Capi.($)
+0.46%+3.37%+68.96%-2.19% 413.11Cr
-0.02%+3.19%-15.56%+6.01% 19TCr
+0.76%+4.72%-1.88%+10.18% 12TCr
+1.43%-2.07%+7.17%+69.23% 5.99TCr
+0.32%+3.92%+37.52%+63.82% 5.6TCr
+0.79%+3.70%-6.40%-34.42% 5TCr
-1.89%+5.90%+10.87%-21.62% 3.39TCr
+0.45%+1.45% - - 3.14TCr
+1.98%+12.62%-2.82%+23.87% 2.48TCr
+0.94%-1.31%+41.93%-13.11% 2.46TCr
Average +0.52%+3.66%+15.53%+11.31% 5.94TCr
Weighted average by Cap. +0.42%+3.41%+1.09%+14.00%

Financials

2027 *2028 *
Net sales 141.48Cr 122.19Cr 114.82Cr 104.43Cr 196.33Cr 14TCr 199.57Cr 1.35TCr 526.04Cr 6.77TCr 531.17Cr 519.64Cr 23TCr 148.9Cr 128.61Cr 120.85Cr 109.91Cr 206.64Cr 14TCr 210.04Cr 1.42TCr 553.65Cr 7.13TCr 559.06Cr 546.92Cr 24TCr
Net income 18Cr 15Cr 14Cr 13Cr 25Cr 1.7TCr 25Cr 168.72Cr 66Cr 849.58Cr 67Cr 65Cr 2.82TCr 21Cr 18Cr 17Cr 15Cr 29Cr 1.98TCr 29Cr 197.07Cr 77Cr 992.32Cr 78Cr 76Cr 3.3TCr
Net Debt 66Cr 57Cr 54Cr 49Cr 92Cr 6.33TCr 93Cr 629.56Cr 246.15Cr 3.17TCr 248.56Cr 243.16Cr 11TCr 33Cr 28Cr 27Cr 24Cr 45Cr 3.13TCr 46Cr 311.09Cr 121.63Cr 1.57TCr 122.82Cr 120.15Cr 5.21TCr
Logo Haemonetics Corporation
Haemonetics Corporation is a medical technology company. Its solutions address critical medical needs, which includes a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers, and products to enable blood centers to collect in-demand blood components. Its Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. Its Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies (Hemostasis Management, Cell Salvage and Transfusion Management products). It also offers solutions for structural heart and endovascular procedures.
Employees
3,009
Date Price Change Volume
14/26/14 $90.80 +0.46% 5,33,283
13/26/13 $90.38 -1.05% 8,11,854
12/26/12 $91.34 +4.72% 8,22,993
11/26/11 $87.22 +0.70% 7,45,392
10/26/10 $86.61 -1.40% 5,71,131
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
90.80USD
Average target price
96.90USD
Spread / Average Target
+6.72%

Quarterly revenue - Rate of surprise